ClinicalTrials.Veeva

Menu

Informational Tool for Smoking Cessation in COPD Patients (IMPACT-BPCO)

H

Hopital Nord Franche-Comte

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Treatments

Other: informational intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06872450
2024-11-IMPACT BPCO

Details and patient eligibility

About

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Full description

implementing a tool in the form of an informational intervention with a specific motivational intervention

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
  • People treated at HNFC
  • Smokers

Exclusion criteria

  • People with cognitive disorders compromising comprehension and completion of the study

Trial design

15 participants in 1 patient group

informational intervention
Description:
informational intervention
Treatment:
Other: informational intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems